Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 8/20 | 0.33 |
| ▸ | CHRM5 | P08912 | 6/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 4/20 | 0.32 |
| ▸ | CHRM4 | P08173 | 3/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL475264 | 0.98 | CHRM2 (0.32) | CHRM2CHRM5CHRM1TSHRMAPK1 | |
| SCHEMBL472196 | 0.71 | — | — | |
| SCHEMBL51214 | 0.70 | — | — | |
| SCHEMBL52033 | 0.69 | — | — | |
| SCHEMBL6906542 | 0.68 | — | — | |
| SCHEMBL8816548 | 0.67 | — | — | |
| Water SCHEMBL5180865 | 0.67 | — | — | |
| SCHEMBL1148886 | 0.67 | — | — | |
| SCHEMBL28738879 | 0.67 | — | — | |
| SCHEMBL29245116 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 136 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105348575-A | Formula of insulating cable jacket encapsulation | WANG WEISONG | 2016-02-24 | — | — | CN | claimed |
| JP-3931217-B2 | — | — | 2007-06-13 | — | — | JP | claimed |
| EP-0764174-B1 | PROCESS FOR REMOVING BILE SALTS FROM A PATIENT AND ALKYLATED COMPOSITIONS THEREFOR | GELTEX PHARMA INC (US) | 1999-09-01 | — | — | EP | claimed |
| US-5917007-A | Process for removing bile salts from a patient and alkylated compositions therefor | GELTEX PHARMACEUTICALS, INC. (US) | 1999-06-29 | — | — | US | claimed |
| EP-0909768-A2 | Process for removing bile salts from a patient and alkylated compositions therefor | GELTEX PHARMACEUTICALS, INC. (US) | 1999-04-21 | — | — | EP | claimed |
| US-5693675-A | Alkylated amine polymers | GELTEX PHARMACEUTICALS INC. (US) | 1997-12-02 | — | — | US | claimed |
| US-5679717-A | Method for removing bile salts from a patient with alkylated amine polymers | GELTEX PHARMACEUTICALS, INC. (US) | 1997-10-21 | — | — | US | claimed |
| EP-0764174-A1 | PROCESS FOR REMOVING BILE SALTS FROM A PATIENT AND ALKYLATED COMPOSITIONS THEREFOR | GELTEX PHARMACEUTICALS, INC. (US) | 1997-03-26 | — | — | EP | claimed |
| WO-1995034585-A1 | PROCESS FOR REMOVING BILE SALTS FROM A PATIENT AND ALKYLATED COMPOSITIONS THEREFOR | GELTEX PHARMACEUTICALS, INC. (US) | 1995-12-21 | — | — | WO | claimed |
| US-6433026-B1 | — | — | None | — | — | US | disclosed |
| US-10905711-B2 | Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammal | VIFOR (INTERNATIONAL) LTD. (CH) | 2021-02-02 | — | — | US | disclosed |
| US-20200085856-A1 | ION BINDING POLYMERS AND USES THEREOF | ILYPSA, INC. | 2020-03-19 | — | — | US | disclosed |
| EP-3574896-A1 | ION BINDING POLYMERS AND USES THEREOF | Relypsa, Inc. (US) | 2019-12-04 | — | — | EP | disclosed |
| US-10485821-B2 | Ion binding polymers and uses thereof | VIFOR (INTERNATIONAL) LTD. (CH) | 2019-11-26 | — | — | US | disclosed |
| US-5679717-A | Method for removing bile salts from a patient with alkylated amine polymers | GELTEX PHARMACEUTICALS, INC. (US) | 1997-10-21 | — | — | US | disclosed |
| US-5624963-A | Process for removing bile salts from a patient and compositions therefor | GELTEX PHARMACEUTICALS, INC. (US) | 1997-04-29 | — | — | US | disclosed |
| EP-0764174-A1 | PROCESS FOR REMOVING BILE SALTS FROM A PATIENT AND ALKYLATED COMPOSITIONS THEREFOR | GELTEX PHARMACEUTICALS, INC. (US) | 1997-03-26 | — | — | EP | disclosed |
| EP-0764177-A1 | CROSS-LINKED POLYMERS FOR REMOVING BILE SALTS FROM A PATIENT | GELTEX PHARMACEUTICALS, INC. (US) | 1997-03-26 | — | — | EP | disclosed |
| WO-1995034588-A1 | CROSS-LINKED POLYMERS FOR REMOVING BILE SALTS FROM A PATIENT | GELTEX PHARMACEUTICALS, INC. (US) | 1995-12-21 | — | — | WO | disclosed |
| WO-1995034585-A1 | PROCESS FOR REMOVING BILE SALTS FROM A PATIENT AND ALKYLATED COMPOSITIONS THEREFOR | GELTEX PHARMACEUTICALS, INC. (US) | 1995-12-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10905711-B2 | Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammal | KCNN3, KCNH3, KCNH2 | CHRM2 2181/4885CHRM5 1461/4885CHRM1 2808/4885 |
| US-20200085856-A1 | ION BINDING POLYMERS AND USES THEREOF | ATP6V1B1, KCNN3, SLC9A3 | CHRM2 4389/4885CHRM5 3565/4885CHRM1 4647/4885 |
| US-10485821-B2 | Ion binding polymers and uses thereof | ATP6V1B1, KCNN3, SLC9A3 | CHRM2 4389/4885CHRM5 3565/4885CHRM1 4647/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.